Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/24/2012US8163769 1,8-naphthyridine derivatives
04/24/2012US8163768 4-(4-Hydroxy-3-methyl-phenyl)-2,4,6,7,8,9-hexahydro-pyrazolo[3,4-b]-1,7-naphthyridin-5-one; inhibiting Aurora kinase; inhibiting the proliferation of tumor cells; cancer, psoriasis, leukaemia and lupus
04/24/2012US8163767 Heterocyclic Janus Kinase 3 inhibitors
04/24/2012US8163766 Beta-secretase modulators and methods of use
04/24/2012US8163765 Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
04/24/2012US8163764 Skincare methods
04/24/2012US8163763 Pyrimidine compounds, compositions and methods of use
04/24/2012US8163762 Purine derivatives having, in particular, anti-proliferative properties, and their biological uses
04/24/2012US8163761 Methods and compositions for treating disorders
04/24/2012US8163760 Use of pyridopyrimidine compounds in the treatment of gliomas
04/24/2012US8163759 Pyrazolo[1,5-A] pyrimidine compounds as CB1 receptor antagonist
04/24/2012US8163758 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
04/24/2012US8163757 Immuno inhibitory pyrazolone compounds
04/24/2012US8163756 For example,1-(3-t-butyl-1- (1,2,3,4-tetrahydro- isoquinolin-6-yl)-1H- pyrazol-5-yl)-3-(3- cyanophenyl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies
04/24/2012US8163755 Hexahydrooxazinopterine compounds
04/24/2012US8163754 Purine derivatives for use as adenosine A-2A receptor agonists
04/24/2012US8163753 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria
04/24/2012US8163752 Tricyclic anilide heterocyclic CGRP receptor antagonists
04/24/2012US8163751 Acylated indanyl amines and their use as pharmaceuticals
04/24/2012US8163750 Fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone HSP 90
04/24/2012US8163749 Six-membered heterocycles useful as serine protease inhibitors
04/24/2012US8163748 s-Triazine compounds, pharmaceutical compositions and method of using the same
04/24/2012US8163747 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms
04/24/2012US8163746 Azolecarboxamide derivative
04/24/2012US8163745 HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
04/24/2012US8163744 Tetrahydro-isoquinolin-1-ones for the treatment of cancer
04/24/2012US8163743 4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases
04/24/2012US8163742 Di-amino-substituted heterocyclic compounds and methods of use
04/24/2012US8163741 Use of aryl-substituted polycyclic amines as medicaments
04/24/2012US8163740 6-substituted benzoxazines
04/24/2012US8163739 2-arylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals
04/24/2012US8163738 Aminodiazepines as toll-like receptor modulators
04/24/2012US8163737 CGRP receptor antagonists
04/24/2012US8163736 Cytotoxic agents comprising new tomaymycin derivatives
04/24/2012US8163735 Sulfonamide compounds as cysteine protease inhibitors
04/24/2012US8163734 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
04/24/2012US8163733 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
04/24/2012US8163732 Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase
04/24/2012US8163731 Method and dosage regimens for eliminating a chemical substance in blood
04/24/2012US8163730 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
04/24/2012US8163729 Modulators of α7 nicotinic acetylcholine receptors and therapeutic uses thereof
04/24/2012US8163728 Pyrazoles
04/24/2012US8163727 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
04/24/2012US8163726 Administering to the mammal with the angiogenesis-mediated disease or condition an amount effective to inhibit, reduce, or prevent angiogenesis of an immunophilin binding active agent, e.g., rapamycin, a rapamycin analog, or tacrolimus ; diabetic retinopathy, macular degeneration
04/24/2012US8163725 Gel compositions and methods of use
04/24/2012US8163724 Glucocorticosteroids, processes for their preparation, pharmaceutical compositions containing them and their use in therapy
04/24/2012US8163723 Combination of azelastine and steroids
04/24/2012US8163722 Pharmaceutical formulation for contraception and hormone-replacement therapy
04/24/2012US8163721 Management of breakthrough bleeding in extended hormonal contraceptive regimens
04/24/2012US8163719 Regulators of the hedgehog pathway, compositions and uses related thereto
04/24/2012US8163718 Nucleoside analogues containing phosphonate or phosphonamide groups
04/24/2012US8163717 Dual chain synthetic heparin-binding growth factor analogs
04/24/2012US8163716 Method of administering hyaluronan formulation for the amelioration of osteophytes
04/24/2012US8163715 Inulin of very high chain length
04/24/2012US8163714 Injectable crosslinked and uncrosslinked alginates and the use thereof in medicine and in cosmetic surgery
04/24/2012US8163713 Trehalose compound and pharmaceutical comprising the compound
04/24/2012US8163710 Reduction of graft-versus-host disease by modulation of SHIP activity
04/24/2012US8163707 4′-allene-substituted nucleoside derivatives
04/24/2012US8163705 Glycolipid and use thereof
04/24/2012US8163704 Glycoside derivatives and uses thereof
04/24/2012US8163703 Hepatitis C therapies
04/24/2012US8163701 Prodrugs of active agents
04/24/2012US8163528 Nucleic acid molecules encoding thymidine kinase fusion proteins
04/24/2012US8163313 Compositions containing amines and use thereof
04/24/2012US8163305 Targeted cross-linked nanoparticles and their use in vivo gene delivery
04/24/2012US8163304 Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents
04/24/2012US8163303 Nutritional composition for the treatment of pressure ulcers
04/24/2012US8163300 Method for enhancing dispersion of inorganic compounds using silicone-containing esters and compositions formed therefrom
04/24/2012US8163299 Stabilized pharmaceutical product
04/24/2012US8163298 Aqueous gel having an alpha-hydroxy acid and suspended particulates
04/24/2012US8163277 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; stent implants
04/24/2012US8163274 Personal care products containing high refractive index esters and methods of preparing the same
04/24/2012US8161969 Dry powder dispersing apparatus and methods for their use
04/24/2012CA2700314C Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
04/24/2012CA2697349C Benzylbenzene derivatives and methods of use
04/24/2012CA2680783C Heterocyclic compounds and their uses
04/24/2012CA2673498C Method for producing c-glycoside derivative and intermediate for synthesis thereof
04/24/2012CA2666437C Method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, a soluble formulation of a pentacyclic or tetracyclic terpenoid and a pharmaceutical composition containing this soluble formulation
04/24/2012CA2661069C Stabilized brood pheromone for manipulating the behavior and physiology of honey bees
04/24/2012CA2645467C Pyridine derivative having anti-helicobacter pylori activity
04/24/2012CA2641221C Method to predict and prevent oxygen-induced inflammatory tissue injury
04/24/2012CA2583589C Processes for preparing glatiramer
04/24/2012CA2576131C Polysulfated glycosides and salts thereof
04/24/2012CA2573754C Substituted amino compounds as 5-ht/na uptake inhibitors
04/24/2012CA2559530C Novel benzyl(idene)-lactam derivatives
04/24/2012CA2551575C Benzopyran derivatives, method of production and use thereof
04/24/2012CA2551411C Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
04/24/2012CA2550302C L-(-)-moprolol l-(+)-tartrate
04/24/2012CA2542361C Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes
04/24/2012CA2538743C Benzylbenzimidazolyl derivatives as kinase inhibitors
04/24/2012CA2534259C Glycyrrhizin high-concentration preparation
04/24/2012CA2525373C Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
04/24/2012CA2524054C Immunosuppressant compounds and compositions
04/24/2012CA2511843C Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
04/24/2012CA2511479C Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
04/24/2012CA2506891C Vitamin d receptor modulators
04/24/2012CA2506290C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
04/24/2012CA2499322C Benzodiapine derivatives and pharmaceutical compositions containing them
04/24/2012CA2494179C Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
04/24/2012CA2493090C New derivatives of benzo[b]chromeno-naphthyridin-1-one and pyrano[2'3':7,8]quino[2,3-b]quinoxalin-7-one, method of preparing said derivatives and pharmaceutical compositions containing said derivatives
1 ... 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 ... 7860